Korro Bio, Inc.
Korro Bio, Inc.（KRRO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
krro · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$30.00
Consensus
$19.57
+84.8% upside
Low
$10.00
Median: $22 · Last Close: $10.59
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.57
84.8% upside
High Target
$30
183.3%
Low Target
$10
-5.6%
Current Price
$10.59
as of today
Based on analyst price targets, the KRRO stock price prediction for the next 12 months ranges from $10 to $30. The consensus KRRO price forecast of $19.57 implies 84.8% upside from the current price of $10.59.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.29 | ↓ 2.87% |
1-day model range: $10.17–$10.4. Peak: $10.4 (-2.87%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $7 | -34.2% |
| 2028 | $6 | -45.4% |
| 2029 | $5 | -50.1% |
| 2030 | $5 | -52.2% |
| 2031 | — | -53.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRRO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-03-13 | Raymond James | Upgrade ↑ | Market Perform→Outperform |
| 2026-02-19 | Clear Street | Upgrade ↑ | Hold→Buy |
| 2026-02-17 | William Blair | Upgrade ↑ | Market Perform→Outperform |
| 2026-01-29 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2026-01-29 | Chardan Capital | Upgrade ↑ | Neutral→Buy |
| 2026-01-29 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2026-01-28 | Oppenheimer | Upgrade ↑ | Perform→Outperform |
| 2026-01-28 | Cantor Fitzgerald | Upgrade ↑ | Neutral→Overweight |
Wall Street analysts have recently issued updated ratings on Korro Bio, Inc. (KRRO) stock. Of the recent 43 rating actions, 8 were upgrades and 6 were downgrades. 12 analysts currently cover KRRO.
分析师推荐趋势
KRRO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↑ 24.2% YoY
Revenue Next Year
$1M
↓ 41.9% YoY
EPS This Year
$-5.32
EPS Next Year
$-5.13
↓ 3.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRRO EPS of $-5.32 for the current fiscal year, based on estimates from 9 analysts. The KRRO revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KRRO 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KRRO 的共识目标价为 $19.57（+84.8% 上行空间），分析师共识为 Buy。
KRRO 的短期预测（明日）为 $10.29（-2.87%）。 KRRO 对 2027 年的股价预测均值为 $7。 KRRO 对 2030 年的预测区间为 $4–$6。
Korro Bio, Inc. 在 NASDAQ 上市，代码 KRRO。KRRO 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
KRRO 预测 · 8 个问题根据 12 位华尔街分析师，KRRO 的 12 个月平均目标价为 $19.57，最高 $30.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $10.59，隐含约 +84.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.